For example, CD33 is a single-chain, trans-membrane glycoprotein, a myeloid differentiation antigen broadly expressed on AML blast cells; therefore, it is an excellent therapeutic target for AML treatment [30,31]. The gene discussed is CD33; the disease is acute myeloid leukemia.